首页 | 本学科首页   官方微博 | 高级检索  
检索        

中药止喘胶囊对哮喘大鼠糖皮质激素受体及皮质酮的影响
引用本文:王宏长,吴红梅,倪伟,吴银根,于素霞.中药止喘胶囊对哮喘大鼠糖皮质激素受体及皮质酮的影响[J].广东医学,2001,22(12):1108-1110.
作者姓名:王宏长  吴红梅  倪伟  吴银根  于素霞
作者单位:上海中医药大学附属龙华医院呼吸内科,
基金项目:国家中医药管理局基金(编号:97Z100),上海市科技发展基金(编号:994119010)资助
摘    要:目的 观察中药止喘胶囊对哮喘大鼠外周血白细胞和肺组织中糖皮质激素受体(GCR)、血浆皮质酮、血浆及肺泡灌洗液(BALF)中白细胞介素-4,5(IL-4,5)的影响,以探讨补肾健脾固本法治疗哮喘的作用机制。方法 采用放射性配基结合法、放射免疫法、酶联免疫法测定各组大鼠外周血白细胞和肺组织中 GCR、血浆皮质酮、血浆及 BALF中 IL-4,5含量。结果 哮喘模型组血浆皮质酮含量、外周血白细胞GCR结合位点和肺组织 GCR的 RT值均明显低于正常组(均P<0.01),中药止喘胶囊组血浆皮质酮含量、肺组织GCR的RT值显著高于正常组(P<0.05,P<0.01);哮喘模型组血浆和 BALF中L-4,IL-5含量均明显高于正常组(均 P<0.01),其余各治疗组均明显下降(均 P<0.01),其中中西药结合组显著低于中药组、西药组(均P<0.01),接近正常组(P>0.05)。结论 止喘胶囊以补肾健脾固本治法通过阻止哮喘大鼠外周血白细胞和肺组织GCR结合位点的下降,上调内源性皮质酮水平,改善下丘脑-垂体-肾上腺功能,下调血浆和 BALF中 IL-4,5,从而减轻哮喘气道炎症,止喘胶囊与吸入激素有一定程度的协同作用。

关 键 词:中药  止喘胶囊  哮喘  糖皮质激素受体  皮质酮  动物实验
修稿时间:2001年7月30日

Effect of ZhiChuan capsule on glucocorticoids receptor and corticosterone in asthmatic rat
Wang Hongchang,We Hongmei,Ni Wei,et al..Effect of ZhiChuan capsule on glucocorticoids receptor and corticosterone in asthmatic rat[J].Guangdong Medical Journal,2001,22(12):1108-1110.
Authors:Wang Hongchang  We Hongmei  Ni Wei  
Institution:Wang Hongchang,We Hongmei,Ni Wei,et al. Department of Respiratory Medicine,Longhua Hospital,Shanghai University of Traditional Chinese Medicine,Shanghai 200032
Abstract:Objective To observe the effect of ZhiChuan capsule on glucocorticoids receptor and corticosterone in asthmatic rat and discuss the mechanism of BuShenJianPiGuBen method of traditional Chinese medicine in treatment of asthma. Methods The levels of glucocorticoids receptor( GCR) , corticosterone and interleukin - 4, 5 (IL - 4, 5) from rat were detected by immunolabelling technique. Results The levels of conjugated site and RT of GCR, corticosterone in model group were lower than that in normal group( P <0.01), but the levels RT of GCR, corticosterone in ZhiChuan capsule - treated group were higher than that in normal group ( P < 0.01 , P <0.05). The levels of IL- 4,5 in ZhiChuan capsule plus glucocorticoids group were significantly lower than that in group of ZhiChuan capsule - treated or glucocorticoids - treated (P <0.01) , and no differences between group of ZhiChuan capsule plus glucocorticoids - treated and normal (P > 0.05). Conclusion One of the mechanism of BuShenJianPiGuBen method in treatment of asthma may be alleviating airway inflammation through blocking down levels of GCR, increasing levels of endogenic corticosterone and reducing levels of IL -4,5. ZhiChuan capsule have part synergy with inhaled glucocorticoids.
Keywords:Traditional Chinese herbs  ZhiChuan capsule  Asthma  Glucocorticoids receptor  Corticosterone  Rat
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号